Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Revue Neurologique
|
April 20, 2010
[Diagnostic processes in aphasia]
H Taillia, V Jego
Targeted Oncology
|
July 9, 2013
A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors
M Mita, M Gordon, N Rejeb, et al.
Investigational New Drugs
|
March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
E Raymond, J Alexandre, S Faivre, et al.
British Journal of Cancer
|
May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
T Macarulla, A Cervantes, J Tabernero, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Revue Neurologique
|
April 20, 2010
[Diagnostic processes in aphasia]
H Taillia, V Jego
Targeted Oncology
|
July 9, 2013
A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors
M Mita, M Gordon, N Rejeb, et al.
Investigational New Drugs
|
March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors
E Raymond, J Alexandre, S Faivre, et al.
British Journal of Cancer
|
May 20, 2015
Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer
T Macarulla, A Cervantes, J Tabernero, et al.
Page
of 1